Want to join the conversation?
CJS Securities analyst Dan Moore follows up asking $JW.A $JW.B what the impact would be on revenue and EPS in FY17 relative to FY16 at current FX rates. CFO John Kritzmacher says that at current rates, the company expects to see still some revenue & EPS erosion, but the erosion would be more on the order of about $10MM revenue & about $0.04 to EPS.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.